Search Results for:

Massachusetts Institute of Technology v. Shire

Goodwin represented MIT and the Children’s Medical Center Corporation in a dispute against Shire Pharmaceuticals, Inc. and Shire Regenerative Medicine, Inc. (collectively, “Shire”) for infringement of two patents concerning the production of a three-dimensional scaffolding that would allow pre-grown cells to produce organ tissue in a patient. Goodwin prevailed in…

Read More

American Freedom Defense Initiative v. Massachusetts Bay Transportation Authority

Goodwin attorneys successfully persuaded the Supreme Court to deny the petition for certiorari in a First Amendment challenge brought by the American Freedom Defense Initiative to the Massachusetts Bay Transportation Authority’s application of its advertising guidelines. The case raised the question of when a public transit authority creates a designated…

Read More

Joseph A. Pakootas et al. v. State of Washington Amicus Brief

Goodwin prepared an amicus brief in the Ninth Circuit in support of Teck Resources, Inc., a Canadian metals and mining company, relating to the types of environmental releases that trigger liability under CERCLA. This case involves the significant issue of whether cross-boundary movement of pollutants into the United States from…

Read More

In re Loestrin 24FE Antitrust Litigation

In the wake of the Supreme Court’s landmark decision in FTC v. Actavis, Goodwin attorneys have been at the forefront of litigating antitrust challenges to settlement agreements between brand and generic pharmaceutical companies. In this case, Goodwin filed an amicus brief on behalf of the Association for Accessible Medicines (formerly…

Read More